nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Dactinomycin—ocular cancer	0.343	0.598	CbGbCtD
Clofarabine—ABCG2—Carboplatin—ocular cancer	0.23	0.402	CbGbCtD
Clofarabine—Venoocclusive disease—Dactinomycin—ocular cancer	0.00847	0.256	CcSEcCtD
Clofarabine—Multi-organ failure—Dactinomycin—ocular cancer	0.003	0.0907	CcSEcCtD
Clofarabine—Febrile neutropenia—Dactinomycin—ocular cancer	0.00162	0.0491	CcSEcCtD
Clofarabine—Hepatotoxicity—Dactinomycin—ocular cancer	0.00126	0.0383	CcSEcCtD
Clofarabine—Necrosis—Dactinomycin—ocular cancer	0.00124	0.0376	CcSEcCtD
Clofarabine—Infection—Carboplatin—ocular cancer	0.000932	0.0282	CcSEcCtD
Clofarabine—Mouth ulceration—Dactinomycin—ocular cancer	0.000883	0.0267	CcSEcCtD
Clofarabine—Sepsis—Dactinomycin—ocular cancer	0.000848	0.0256	CcSEcCtD
Clofarabine—Pain—Carboplatin—ocular cancer	0.000803	0.0243	CcSEcCtD
Clofarabine—Body temperature increased—Carboplatin—ocular cancer	0.000742	0.0224	CcSEcCtD
Clofarabine—Lethargy—Dactinomycin—ocular cancer	0.000723	0.0219	CcSEcCtD
Clofarabine—POLA1—DNA Replication Pre-Initiation—E2F1—ocular cancer	0.000705	0.00179	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CDK2—ocular cancer	0.000701	0.00178	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN1A—ocular cancer	0.000692	0.00176	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00069	0.00175	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000686	0.00174	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.000685	0.00174	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—E2F5—ocular cancer	0.000678	0.00172	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.000665	0.00169	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—E2F4—ocular cancer	0.000665	0.00169	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.000665	0.00169	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.000662	0.00168	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDK2—ocular cancer	0.00066	0.00168	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—EP300—ocular cancer	0.000659	0.00167	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000652	0.00165	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—E2F2—ocular cancer	0.000652	0.00165	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RBL1—ocular cancer	0.000652	0.00165	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000644	0.00164	CbGpPWpGaD
Clofarabine—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.000638	0.0193	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.000638	0.0193	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00063	0.0016	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000622	0.00158	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN1B—ocular cancer	0.000618	0.00157	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication Pre-Initiation—CDK2—ocular cancer	0.000608	0.00154	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—E2F5—ocular cancer	0.000607	0.00154	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000602	0.00153	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000598	0.00152	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—E2F2—ocular cancer	0.000596	0.00151	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—E2F4—ocular cancer	0.000594	0.00151	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYBL2—ocular cancer	0.000594	0.00151	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00059	0.0015	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000588	0.00149	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RBL1—ocular cancer	0.000583	0.00148	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—E2F2—ocular cancer	0.000583	0.00148	CbGpPWpGaD
Clofarabine—Pancytopenia—Dactinomycin—ocular cancer	0.000582	0.0176	CcSEcCtD
Clofarabine—POLA1—DNA Replication—E2F1—ocular cancer	0.000577	0.00146	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—RB1—ocular cancer	0.000576	0.00146	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—MYC—ocular cancer	0.000574	0.00146	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.000574	0.00146	CbGpPWpGaD
Clofarabine—Neutropenia—Dactinomycin—ocular cancer	0.000573	0.0173	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—CDKN1A—ocular cancer	0.00057	0.00145	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.000569	0.00144	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.000569	0.00144	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000565	0.00143	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000565	0.00143	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000558	0.00142	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.000558	0.00142	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—E2F1—ocular cancer	0.000556	0.00141	CbGpPWpGaD
Clofarabine—Pneumonia—Dactinomycin—ocular cancer	0.00055	0.0166	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000549	0.00139	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000543	0.00138	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—RB1—ocular cancer	0.000543	0.00138	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.000542	0.00138	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—EP300—ocular cancer	0.000542	0.00138	CbGpPWpGaD
Clofarabine—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.000542	0.0164	CcSEcCtD
Clofarabine—RRM1—Metabolism—PSPH—ocular cancer	0.00054	0.00137	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000538	0.00136	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000537	0.00136	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RBL2—ocular cancer	0.000535	0.00136	CbGpPWpGaD
Clofarabine—Stomatitis—Dactinomycin—ocular cancer	0.000533	0.0161	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDK2—ocular cancer	0.000531	0.00135	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000525	0.00133	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—E2F3—ocular cancer	0.000517	0.00131	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000513	0.0013	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000512	0.0013	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00051	0.00129	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—E2F3—ocular cancer	0.000505	0.00128	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RBBP4—ocular cancer	0.000505	0.00128	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000502	0.00127	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000499	0.00127	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2C—ocular cancer	0.000499	0.00127	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—CDK2—ocular cancer	0.000498	0.00126	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000495	0.00126	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000485	0.00123	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDC25A—ocular cancer	0.000481	0.00122	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CDK2—ocular cancer	0.000479	0.00122	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000479	0.00121	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000476	0.00121	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—MYC—ocular cancer	0.000473	0.0012	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000472	0.0012	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TFDP1—ocular cancer	0.00047	0.00119	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.000468	0.00119	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—E2F5—ocular cancer	0.000464	0.00118	CbGpPWpGaD
Clofarabine—Erythema multiforme—Dactinomycin—ocular cancer	0.000464	0.014	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000463	0.00117	CbGpPWpGaD
Clofarabine—Flushing—Dactinomycin—ocular cancer	0.000455	0.0138	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—E2F4—ocular cancer	0.000455	0.00115	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.000455	0.00115	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CDKN1B—ocular cancer	0.000448	0.00114	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—E2F2—ocular cancer	0.000446	0.00113	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RBL1—ocular cancer	0.000446	0.00113	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PSPH—ocular cancer	0.000445	0.00113	CbGpPWpGaD
Clofarabine—Chills—Dactinomycin—ocular cancer	0.00044	0.0133	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—RB1—ocular cancer	0.000436	0.00111	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDK2—ocular cancer	0.000435	0.0011	CbGpPWpGaD
Clofarabine—Alopecia—Dactinomycin—ocular cancer	0.000433	0.0131	CcSEcCtD
Clofarabine—Erythema—Dactinomycin—ocular cancer	0.000427	0.0129	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND3—ocular cancer	0.000426	0.00108	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN1B—ocular cancer	0.000423	0.00107	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PSPH—ocular cancer	0.000415	0.00105	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—E2F5—ocular cancer	0.000415	0.00105	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CDKN1A—ocular cancer	0.000414	0.00105	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDK4—ocular cancer	0.000411	0.00104	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000411	0.00104	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00041	0.00104	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000409	0.00104	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—RB1—ocular cancer	0.000409	0.00104	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—E2F4—ocular cancer	0.000406	0.00103	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYBL2—ocular cancer	0.000406	0.00103	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000404	0.00102	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000402	0.00102	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—E2F2—ocular cancer	0.000399	0.00101	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RBL1—ocular cancer	0.000399	0.00101	CbGpPWpGaD
Clofarabine—Anaemia—Dactinomycin—ocular cancer	0.000395	0.0119	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—RB1—ocular cancer	0.000394	0.000999	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN1A—ocular cancer	0.00039	0.00099	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000387	0.000981	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000387	0.000981	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000387	0.000981	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000384	0.000974	CbGpPWpGaD
Clofarabine—Leukopenia—Dactinomycin—ocular cancer	0.000382	0.0116	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000382	0.000969	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000381	0.000966	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000378	0.000959	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.000374	0.000949	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—EP300—ocular cancer	0.000371	0.000942	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000368	0.000933	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000367	0.000932	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RBL2—ocular cancer	0.000366	0.000929	CbGpPWpGaD
Clofarabine—Myalgia—Dactinomycin—ocular cancer	0.000363	0.011	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00036	0.000915	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000359	0.000912	CbGpPWpGaD
Clofarabine—POLA1—S Phase—RB1—ocular cancer	0.000358	0.000907	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000355	0.000901	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000355	0.0009	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00035	0.000889	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000349	0.000885	CbGpPWpGaD
Clofarabine—Oedema—Dactinomycin—ocular cancer	0.000348	0.0105	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000348	0.000882	CbGpPWpGaD
Clofarabine—Infection—Dactinomycin—ocular cancer	0.000346	0.0105	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—RBBP4—ocular cancer	0.000346	0.000877	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—E2F3—ocular cancer	0.000346	0.000877	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—ocular cancer	0.000343	0.00087	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Dactinomycin—ocular cancer	0.000341	0.0103	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDKN1B—ocular cancer	0.000339	0.000861	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000339	0.00086	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000337	0.000856	CbGpPWpGaD
Clofarabine—Anorexia—Dactinomycin—ocular cancer	0.000332	0.01	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000332	0.000842	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000332	0.000841	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDC25A—ocular cancer	0.000329	0.000834	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000326	0.000827	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—MYC—ocular cancer	0.000323	0.000821	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TFDP1—ocular cancer	0.000321	0.000815	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000321	0.000814	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—CDKN1B—ocular cancer	0.000318	0.000808	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000318	0.000807	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000317	0.00961	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDK6—ocular cancer	0.000317	0.000805	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000315	0.0008	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—CDKN1A—ocular cancer	0.000313	0.000795	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CDKN1B—ocular cancer	0.000307	0.000778	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000306	0.000776	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000305	0.000774	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000305	0.000774	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000305	0.000774	CbGpPWpGaD
Clofarabine—Decreased appetite—Dactinomycin—ocular cancer	0.000303	0.00916	CcSEcCtD
Clofarabine—Fatigue—Dactinomycin—ocular cancer	0.0003	0.00909	CcSEcCtD
Clofarabine—Pain—Dactinomycin—ocular cancer	0.000298	0.00902	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CDKN1A—ocular cancer	0.000294	0.000746	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND3—ocular cancer	0.000291	0.000739	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000289	0.000734	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000289	0.000734	CbGpPWpGaD
Clofarabine—Feeling abnormal—Dactinomycin—ocular cancer	0.000287	0.00869	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000285	0.00862	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDKN1A—ocular cancer	0.000283	0.000718	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000281	0.000713	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDKN1B—ocular cancer	0.000278	0.000706	CbGpPWpGaD
Clofarabine—Body temperature increased—Dactinomycin—ocular cancer	0.000275	0.00833	CcSEcCtD
Clofarabine—Abdominal pain—Dactinomycin—ocular cancer	0.000275	0.00833	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000274	0.000695	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000274	0.000694	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—HDAC1—ocular cancer	0.000273	0.000692	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND2—ocular cancer	0.000273	0.000692	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000266	0.000675	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCND1—ocular cancer	0.000266	0.000674	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000265	0.000673	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000258	0.000656	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDKN1A—ocular cancer	0.000257	0.000652	CbGpPWpGaD
Clofarabine—Hypersensitivity—Dactinomycin—ocular cancer	0.000257	0.00777	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000251	0.000637	CbGpPWpGaD
Clofarabine—Asthenia—Dactinomycin—ocular cancer	0.00025	0.00756	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000246	0.000626	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2B—ocular cancer	0.000245	0.000621	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000243	0.000617	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000243	0.000616	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000238	0.000605	CbGpPWpGaD
Clofarabine—Diarrhoea—Dactinomycin—ocular cancer	0.000238	0.00721	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—MYC—ocular cancer	0.000235	0.000595	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000231	0.000586	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—E2F1—ocular cancer	0.00023	0.000583	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—E2F1—ocular cancer	0.000225	0.00057	CbGpPWpGaD
Clofarabine—Vomiting—Dactinomycin—ocular cancer	0.000222	0.0067	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00022	0.000558	CbGpPWpGaD
Clofarabine—Rash—Dactinomycin—ocular cancer	0.00022	0.00665	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000218	0.000554	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK6—ocular cancer	0.000217	0.000551	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000217	0.00055	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000214	0.000544	CbGpPWpGaD
Clofarabine—POLA1—S Phase—MYC—ocular cancer	0.000213	0.000541	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000209	0.00053	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000209	0.00053	CbGpPWpGaD
Clofarabine—Nausea—Dactinomycin—ocular cancer	0.000207	0.00626	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000205	0.000519	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.000198	0.000503	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000198	0.000502	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000196	0.000497	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDK2—ocular cancer	0.000194	0.000491	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000187	0.000475	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000187	0.000474	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND2—ocular cancer	0.000187	0.000474	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—HDAC1—ocular cancer	0.000187	0.000474	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000184	0.000468	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDK4—ocular cancer	0.000183	0.000464	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000181	0.000458	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RB1—ocular cancer	0.000178	0.000452	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000172	0.000436	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000172	0.000436	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GNA11—ocular cancer	0.00017	0.000431	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2B—ocular cancer	0.000167	0.000425	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PSPH—ocular cancer	0.000166	0.000422	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000163	0.000413	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RB1—ocular cancer	0.000159	0.000404	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GNAQ—ocular cancer	0.000158	0.000401	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—E2F1—ocular cancer	0.000154	0.00039	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00015	0.00038	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000149	0.000379	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000148	0.000376	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00014	0.000355	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GNA11—ocular cancer	0.00014	0.000355	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000139	0.000352	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MDM2—ocular cancer	0.000136	0.000344	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000133	0.000337	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK2—ocular cancer	0.000132	0.000336	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000132	0.000335	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GNA11—ocular cancer	0.000131	0.000332	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GNAQ—ocular cancer	0.00013	0.00033	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000128	0.000324	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK4—ocular cancer	0.000125	0.000318	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—ocular cancer	0.000124	0.000314	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000123	0.000312	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RB1—ocular cancer	0.000122	0.000309	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—EP300—ocular cancer	0.000122	0.000309	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GNAQ—ocular cancer	0.000122	0.000308	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND1—ocular cancer	0.000118	0.0003	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1A—ocular cancer	0.000114	0.00029	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RB1—ocular cancer	0.000109	0.000276	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—EP300—ocular cancer	0.000109	0.000276	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—ocular cancer	0.000106	0.000269	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000104	0.000264	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—ocular cancer	9.48e-05	0.000241	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	9.48e-05	0.00024	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—ocular cancer	9.28e-05	0.000236	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—ocular cancer	9.04e-05	0.000229	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	8.75e-05	0.000222	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—ocular cancer	8.47e-05	0.000215	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—EP300—ocular cancer	8.32e-05	0.000211	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—ocular cancer	8.08e-05	0.000205	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—ocular cancer	7.82e-05	0.000198	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—ocular cancer	7.79e-05	0.000198	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—EP300—ocular cancer	7.44e-05	0.000189	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—ocular cancer	7.25e-05	0.000184	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—ocular cancer	6.48e-05	0.000165	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—EP300—ocular cancer	5.68e-05	0.000144	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—ocular cancer	5.32e-05	0.000135	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNA11—ocular cancer	5.23e-05	0.000133	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNAQ—ocular cancer	4.86e-05	0.000123	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—EP300—ocular cancer	4.67e-05	0.000119	CbGpPWpGaD
Clofarabine—DCK—Metabolism—EP300—ocular cancer	4.37e-05	0.000111	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—ocular cancer	3.43e-05	8.7e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—ocular cancer	2.82e-05	7.17e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—ocular cancer	2.64e-05	6.7e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EP300—ocular cancer	1.75e-05	4.44e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—ocular cancer	1.06e-05	2.68e-05	CbGpPWpGaD
